Gray Faculty Joins Israel’s New National Biotechnology Innovation Center
The Gray Faculty of Medical and Health Sciences is a partner in the newly established Israel National Biotechnology Innovation Center (INBI), bringing together leading academic institutions and medical centers to advance biomedical research toward clinical application.
The Gray Faculty of Medical and Health Sciences at Tel Aviv University is a partner in the newly established Israel National Biotechnology Innovation Center (INBI), a national initiative bringing together leading research institutions and medical centers across Israel.
INBI will promote biomedical research and accelerate the development of new treatments, with the goal of bridging the gap between scientific discovery and application and advancing promising research toward new therapeutics.
The Faculty joins partners from Israel’s hospitals and healthcare organizations, including Sheba Medical Center, Beilinson Hospital - Rabin Medical Center, Tel Aviv Sourasky Medical Center - Ichilov, Maccabi Healthcare Services, and Clalit Health Services.
Other participating academic institutions and medical centers include Bar-Ilan University, Ben-Gurion University of the Negev, Hadassah Medical Center, the Hebrew University of Jerusalem, Rambam Health Care Campus, Shaare Zedek Medical Center, the Technion - Israel Institute of Technology, the University of Haifa, and the Weizmann Institute of Science.
INBI will be headed by Dr. Anat Cohen-Dayag. In its first stage, the center will focus on building the organization, advancing the project selection process, securing the resources required for implementation, and preparing to launch its first project cycle in 2027.
Special thanks to Sam Mudd and Tom Rice for their work in bringing the initiative to this stage.
Related Articles
